nach oben

Erschienen in:

01.05.2011 | Original paper

Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women

verfasst von: Geoffrey C. Kabat, Mimi Kim, Amanda I. Phipps, Christopher I. Li, Catherine R. Messina, Jean Wactawski-Wende, Lewis Kuller, Michael S. Simon, Shagufta Yasmeen, Sylvia Wassertheil-Smoller, Thomas E. Rohan

Erschienen in: Cancer Causes & Control | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Little is known about the risk factors for triple-negative breast cancer (TNBC), which has a worse prognosis compared to hormone receptor-positive breast cancer. We examined the association of smoking and alcohol intake with TNBC and estrogen receptor-positive (ER+) breast cancer.

Methods

Among 148,030 women enrolled in the Women’s Health Initiative, 300 TNBC cases and 2,479 ER+ cases were identified over a median of 8.0 years of follow-up. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI).

Results

Cigarette smoking was not associated with TNBC, whereas drinkers had reduced risk compared to never drinkers. In contrast, both exposures showed slight positive associations with ER+ breast cancer: for women with ≥40 pack-years of smoking, the HR was 1.24, 95% CI 1.06–1.44; for women consuming ≥7 servings of alcohol per week, the HR was 1.26, 95% CI 1.06–1.50. Intakes of wine and hard liquor were also significantly positively associated with ER+ breast cancer.

Conclusions

These findings from a large cohort of postmenopausal women suggest that smoking and alcohol consumption are not associated with increased risk of TNBC, but may be modestly associated with increased risk of ER+ breast cancer.

Nur mit Berechtigung zugänglich

Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150PubMedCrossRef

Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumors. Nature 406:747–752PubMedCrossRef

Sørlie T, Perou CM, Tibsirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874PubMedCrossRef

Carey LA, Winer E, Viale G, Cameron D, Gianni L (2010) Triple-negative breast cancer: disease entity or title of convenience. Nat Rev Clin Oncol. doi:10.1038/nrclinonc.2010.154

Parise CA, Bauer KR, Brown MM, Caggiano V (2009) Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999–2004. Breast J 15:593–602PubMedCrossRef

Livasy CA, Karaca G, Nanda R et al (2006) Phenotypic evaluation of the basal-like subtype of invasive breast cancer. Mod Pathol 19:264–271PubMedCrossRef

Kreike B, van Kouwenhove M, Horlings H, et al. (2007) Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res 9:R65 doi:10.1186/bcr1771

Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434PubMedCrossRef

Haffty BG, Yang Q, Reiss M et al (2006) Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24:5652–5657PubMedCrossRef

10.

Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor(PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry. Cancer 109:1721–1728PubMedCrossRef

11.

Morris GJ, Naidu S, Topham AK et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and caucasian patients. Cancer 110:876–884PubMedCrossRef

12.

Lund MJ, Trivers KF, Porter PL et al (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113:357–370PubMedCrossRef

13.

Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16:439–443PubMedCrossRef

14.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521–1526PubMedCrossRef

15.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:2078–2086PubMedCrossRef

16.

Millikan RC, Newman B, Tse C-K (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139PubMedCrossRef

17.

Dolle JM, Daling JR, White E et al (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 18:1157–1166PubMedCrossRef

18.

Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11:R31. doi:101186/bcr2261 PubMedCrossRef

19.

Trivers KF, Lund MJ, Porter PL et al (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20:1071–1082PubMedCrossRef

20.

Longnecker MP (1994) Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 5:73–82PubMedCrossRef

21.

Collaborative Group on Hormonal Factors in Breast Cancer (2002) Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women with the disease. Br J Cancer 87:1234–1245CrossRef

22.

Key J, Hodgson S, Omar RZ et al (2006) Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17:759–770PubMedCrossRef

23.

Terry PD, Rohan TE (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11:953–971PubMed

24.

Ahern TP, Lash TL, Egan KM, Baron JA (2009) Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control 20:1837–1844PubMedCrossRef

25.

TheWomen’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19:61–109CrossRef

26.

Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The Women’s Health Initiative observational study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107–S121PubMedCrossRef

27.

Anderson GL, Manson J, Wallace R et al (2003) Implementation of the Women’s Health Initiative study design. Ann Epidemiol 13:S5–S17PubMedCrossRef

28.

Curb JD, McTiernan A, Heckbert SR, et al. (2003) Outcomes ascertainment and adjudication methods in the women’s health initiative. Ann Epidemiol (9 Suppl): S122–S128

29.

Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T (1999) Measurement characteristics of the Women’s Health Initiative food frequency questionnaire. Ann Epidemiol 9:178–187PubMedCrossRef

30.

Kabat GC, Kim M, Kakani C, et al. (2010) Cigarette smoking in relation to risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women. Am J Epidemiol doi:10.1093/aje/kwq159

31.

O’Connell DL, Hulka BS, Chambless LE, Wilkinson WE, Deubner DC (1987) Cigarette smoking, alcohol consumption, and breast cancer risk. J Natl Cancer Inst 78:229–234PubMed

32.

Rohan TE, Baron JA (1989) Cigarette smoking and breast cancer. Am J Epidemiol 129:36–42PubMed

33.

Ewertz M (1990) Smoking and breast cancer risk in Denmark. Cancer Causes Control 1:31–37PubMedCrossRef

34.

Chu SY, Stroup NE, Wingo PA, Lee NC, Peterson HB, Gwinn ML (1990) Cigarette smoking and the risk of breast cancer. Am J Epidemiol 131:244–253PubMed

35.

Field NA, Baptiste MS, Nasca PC, Metzger BB (1992) Cigarette smoking and breast cancer. Int J Epidemiol 21:842–848PubMedCrossRef

36.

Smith SJ, Deacon JM, Chilvers CE (1994) Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk in young women. UK National Case–control study group. Br J Cancer 70:112–119PubMedCrossRef

37.

Baron JA, Newcomb PA, Longnecker MP et al (1996) Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev 5:399–403PubMed

38.

Egan KM, Stampfer MJ, Hunter D et al (2002) Active and passive smoking and breast cancer: prospective results from the nurses’ health study. Epidemiology 13:138–145PubMedCrossRef

39.

Reynolds P, Hurley S, Goldberg DE et al (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California teachers study. J Natl Cancer Inst 96:29–37PubMedCrossRef

40.

Gram IT, Braaten T, Terry PD et al (2005) Breast cancer risk among women who started smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14:61–66PubMed

41.

Olson JE, Vachon CM, Vierkant RA et al (2005) Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer. Mayo Clin Proc 80:1423–1428PubMedCrossRef

42.

Cui Y, Miller AB, Rohan TE (2006) Cigarette smoking and breast cancer risk: update on a prospective cohort study. Breast Cancer Res Treat 100:293–299PubMedCrossRef

43.

Li CI, Malone KE, Daling JR (2005) The relationship between various measures of smoking and risk of breast cancer among older women 65–79 years of age (United States). Cancer Causes Control 16:975–985PubMedCrossRef

44.

London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner BA, Speizer FE (1989) Prospective study of smoking and risk of breast cancer. J Natl Cancer Inst 81:1625–1631PubMedCrossRef

45.

Cooper JA, Rohan TE, Cant ELM, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by estrogen receptor status. Br J Cancer 59:119–125PubMedCrossRef

46.

Yoo K, Tajima K, Miura S et al (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 146:307–314PubMed

47.

Morabia A, Bernstein M, Ruiz J, Heritier S, Berger SD, Borisch B (1998) Relation of smoking to breast cancer by estrogen receptor status. Int J Cancer 75:339–342PubMedCrossRef

48.

Manjer J, Malina J, Berglund G, Lennart B, Garne JP, Janzon L (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91:580–584PubMedCrossRef

49.

Gammon MD, Eng SM, Teitelbaum SL et al (2004) Environmental tobacco smoke and breast cancer incidence. Environmental Res 96:176–185CrossRef

50.

Al-Delaimy WK, Cho E, Chen WY, Colditz G, Willett WC (2004) A prospective study of smoking and risk of breast cancer young adult women. Cancer Epidemiol Biomarkers Prev 13:398–404PubMed

51.

Suzuki R, Orsini N, Mignone L, Saji S, Wolk A (2008) Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status–a meta-analysis of epidemiological studies. Int J Cancer 122:1832–1841PubMedCrossRef

52.

Li Y, Baer D, Friedman GD, Udaltsova N, Shim V, Klatsky AL (2009) Wine, liquor, beer and risk of breast cancer in a large population. Europ J Cancer 45:843–850CrossRef

53.

Lew JQ, Freedman ND, Leitzmann MF et al (2009) Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women. Am J Epidemiol 170:308–317PubMedCrossRef

54.

Li CI, Chlebowski RT, Freiberg M et al (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the Women’s Health Initiative observational study. J Natl Cancer Inst 102:1–10CrossRef

55.

Dorgan JF, Baer DJ, Albert PS et al (2001) Serum hormones and the alcohol breast cancer association in postmenopausal women. J Natl Cancer Inst 93:710–715PubMedCrossRef

56.

Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Barbieri RL (1995) The effects of ethanol on the clearance of estradiol in postmenopausal women. Fertil Steril 63:1227–1230PubMed

Titel: Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women
verfasst von: Geoffrey C. Kabat
Mimi Kim
Amanda I. Phipps
Christopher I. Li
Catherine R. Messina
Jean Wactawski-Wende
Lewis Kuller
Michael S. Simon
Shagufta Yasmeen
Sylvia Wassertheil-Smoller
Thomas E. Rohan
Publikationsdatum: 01.05.2011
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 5/2011
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-011-9750-7

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2011

Non-cancer mortality among people diagnosed with lymphohaematopoietic neoplasm in Australia

Relationship between height at diagnosis and bone tumours in young people: a meta-analysis

Oropharyngeal cancer incidence trends: diminishing racial disparities

Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review

Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer

Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can)

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie